APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rabies Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rabies Diagnosis Market Outlook and Growth Opportunities 2026

Report ID 17422542043 May 2026181 pages

Choose your research edition.

Industry ResearchRabies Diagnosis Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Diagnosis Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Rabies Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Diagnosis Market Outlook and Growth Opportunities 2026181 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Diagnosis Market Analysis and Forecast 2026-2032255 pages · $4,950 USD

Market perspective

The global Rabies Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rabies Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rabies Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rabies Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rabies Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rabies Diagnosis market include Bio-Rad Laboratories, Merck KGaA, Aviva Systems Biology, Creative Diagnostics, MyBioSource, Abbexa Ltd, Norgen Biotek and EXPRESS BIOTECH INTERNATIONAL, INC., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Rabies Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rabies Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rabies Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Rabies Diagnosis market.

Rabies Diagnosis Segment by Company

Bio-Rad Laboratories

Merck KGaA

Aviva Systems Biology

Creative Diagnostics

MyBioSource

Abbexa Ltd

Norgen Biotek

EXPRESS BIOTECH INTERNATIONAL, INC.

Rabies Diagnosis Segment by Type

ELISA

PCR

Others

Rabies Diagnosis Segment by Application

Hospital

Clinic

Others

Rabies Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rabies Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Rabies Diagnosis key companies, revenue, market share, and recent developments.

3. To split the Rabies Diagnosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Rabies Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rabies Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Rabies Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rabies Diagnosis industry.

Chapter 3: Detailed analysis of Rabies Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Rabies Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Rabies Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rabies Diagnosis Industry Trends Table 2. Rabies Diagnosis Industry Drivers Table 3. Rabies Diagnosis Industry Opportunities and Challenges Table 4. Rabies Diagnosis Industry Restraints Table 5. Global Rabies Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rabies Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Rabies Diagnosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Rabies Diagnosis Key Company Manufacturing Base & Headquarters Table 9. Global Rabies Diagnosis Company, Product Type & Application Table 10. Global Rabies Diagnosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Rabies Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of ELISA Table 15. Significant Companies of PCR Table 16. Significant Companies of Others Table 17. Global Rabies Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Rabies Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Rabies Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Rabies Diagnosis Sales Value Share by Type (2021-2026) Table 21. Global Rabies Diagnosis Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Clinic Table 24. Significant Companies of Others Table 25. Global Rabies Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Rabies Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Rabies Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Rabies Diagnosis Sales Value Share by Application (2021-2026) Table 29. Global Rabies Diagnosis Sales Value Share by Application (2027-2032) Table 30. Global Rabies Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Rabies Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Rabies Diagnosis Sales Value Share by Region (2021-2026) Table 33. Global Rabies Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Rabies Diagnosis Sales Value Share by Region (2027-2032) Table 35. Global Rabies Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Rabies Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Rabies Diagnosis Sales Value Market Share by Country (2021-2026) Table 38. Global Rabies Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Rabies Diagnosis Sales Value Market Share by Country (2027-2032) Table 40. Bio-Rad Laboratories Company Information Table 41. Bio-Rad Laboratories Business Overview Table 42. Bio-Rad Laboratories Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Bio-Rad Laboratories Rabies Diagnosis Product Portfolio Table 44. Bio-Rad Laboratories Recent Development Table 45. Merck KGaA Company Information Table 46. Merck KGaA Business Overview Table 47. Merck KGaA Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Merck KGaA Rabies Diagnosis Product Portfolio Table 49. Merck KGaA Recent Development Table 50. Aviva Systems Biology Company Information Table 51. Aviva Systems Biology Business Overview Table 52. Aviva Systems Biology Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Aviva Systems Biology Rabies Diagnosis Product Portfolio Table 54. Aviva Systems Biology Recent Development Table 55. Creative Diagnostics Company Information Table 56. Creative Diagnostics Business Overview Table 57. Creative Diagnostics Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Creative Diagnostics Rabies Diagnosis Product Portfolio Table 59. Creative Diagnostics Recent Development Table 60. MyBioSource Company Information Table 61. MyBioSource Business Overview Table 62. MyBioSource Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MyBioSource Rabies Diagnosis Product Portfolio Table 64. MyBioSource Recent Development Table 65. Abbexa Ltd Company Information Table 66. Abbexa Ltd Business Overview Table 67. Abbexa Ltd Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Abbexa Ltd Rabies Diagnosis Product Portfolio Table 69. Abbexa Ltd Recent Development Table 70. Norgen Biotek Company Information Table 71. Norgen Biotek Business Overview Table 72. Norgen Biotek Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Norgen Biotek Rabies Diagnosis Product Portfolio Table 74. Norgen Biotek Recent Development Table 75. EXPRESS BIOTECH INTERNATIONAL, INC. Company Information Table 76. EXPRESS BIOTECH INTERNATIONAL, INC. Business Overview Table 77. EXPRESS BIOTECH INTERNATIONAL, INC. Rabies Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. EXPRESS BIOTECH INTERNATIONAL, INC. Rabies Diagnosis Product Portfolio Table 79. EXPRESS BIOTECH INTERNATIONAL, INC. Recent Development Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Rabies Diagnosis Product Image Figure 2. Global Rabies Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Rabies Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. ELISA Image Figure 8. PCR Image Figure 9. Others Image Figure 10. Global Rabies Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Rabies Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Rabies Diagnosis Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Others Image Figure 16. Global Rabies Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rabies Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Rabies Diagnosis Sales Value Share by Application (2021-2032) Figure 19. Global Rabies Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Rabies Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Rabies Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 22. North America Rabies Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Rabies Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Rabies Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Rabies Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Rabies Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Rabies Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 28. South America Rabies Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Rabies Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Rabies Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Rabies Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • PCR
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Bio-Rad Laboratories
  • Merck KGaA
  • Aviva Systems Biology
  • Creative Diagnostics
  • MyBioSource
  • Abbexa Ltd
  • Norgen Biotek
  • EXPRESS BIOTECH INTERNATIONAL, INC.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rabies Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rabies Diagnosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Rabies Diagnosis Market Dynamics
  1. 2.1 Rabies Diagnosis Industry Trends
  2. 2.2 Rabies Diagnosis Industry Drivers
  3. 2.3 Rabies Diagnosis Industry Opportunities and Challenges
  4. 2.4 Rabies Diagnosis Industry Restraints
3 Rabies Diagnosis Market by Company
  1. 3.1 Global Rabies Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Rabies Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Rabies Diagnosis Company Ranking (2024-2026)
  4. 3.4 Global Rabies Diagnosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Rabies Diagnosis Company Product Type and Application
  6. 3.6 Global Rabies Diagnosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Rabies Diagnosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Rabies Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Rabies Diagnosis Market by Type
  1. 4.1 Rabies Diagnosis Type Introduction
  2. 4.1.1 ELISA
  3. 4.1.2 PCR
  4. 4.1.3 Others
  5. 4.2 Global Rabies Diagnosis Sales Value by Type
  6. 4.2.1 Global Rabies Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Rabies Diagnosis Sales Value by Type (2021-2032)
  8. 4.2.3 Global Rabies Diagnosis Sales Value Share by Type (2021-2032)
5 Rabies Diagnosis Market by Application
  1. 5.1 Rabies Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Rabies Diagnosis Sales Value by Application
  6. 5.2.1 Global Rabies Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rabies Diagnosis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Rabies Diagnosis Sales Value Share by Application (2021-2032)
6 Rabies Diagnosis Regional Value Analysis
  1. 6.1 Global Rabies Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rabies Diagnosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Rabies Diagnosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Rabies Diagnosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rabies Diagnosis Sales Value (2021-2032)
  7. 6.3.2 North America Rabies Diagnosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Rabies Diagnosis Sales Value (2021-2032)
  10. 6.4.2 Europe Rabies Diagnosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Rabies Diagnosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Rabies Diagnosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Rabies Diagnosis Sales Value (2021-2032)
  16. 6.6.2 South America Rabies Diagnosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Rabies Diagnosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Rabies Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Rabies Diagnosis Country-level Value Analysis
  1. 7.1 Global Rabies Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rabies Diagnosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Rabies Diagnosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Rabies Diagnosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Rabies Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Rabies Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Rabies Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bio-Rad Laboratories
  2. 8.1.1 Bio-Rad Laboratories Company Information
  3. 8.1.2 Bio-Rad Laboratories Business Overview
  4. 8.1.3 Bio-Rad Laboratories Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bio-Rad Laboratories Rabies Diagnosis Product Portfolio
  6. 8.1.5 Bio-Rad Laboratories Recent Developments
  7. 8.2 Merck KGaA
  8. 8.2.1 Merck KGaA Company Information
  9. 8.2.2 Merck KGaA Business Overview
  10. 8.2.3 Merck KGaA Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck KGaA Rabies Diagnosis Product Portfolio
  12. 8.2.5 Merck KGaA Recent Developments
  13. 8.3 Aviva Systems Biology
  14. 8.3.1 Aviva Systems Biology Company Information
  15. 8.3.2 Aviva Systems Biology Business Overview
  16. 8.3.3 Aviva Systems Biology Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aviva Systems Biology Rabies Diagnosis Product Portfolio
  18. 8.3.5 Aviva Systems Biology Recent Developments
  19. 8.4 Creative Diagnostics
  20. 8.4.1 Creative Diagnostics Company Information
  21. 8.4.2 Creative Diagnostics Business Overview
  22. 8.4.3 Creative Diagnostics Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Creative Diagnostics Rabies Diagnosis Product Portfolio
  24. 8.4.5 Creative Diagnostics Recent Developments
  25. 8.5 MyBioSource
  26. 8.5.1 MyBioSource Company Information
  27. 8.5.2 MyBioSource Business Overview
  28. 8.5.3 MyBioSource Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MyBioSource Rabies Diagnosis Product Portfolio
  30. 8.5.5 MyBioSource Recent Developments
  31. 8.6 Abbexa Ltd
  32. 8.6.1 Abbexa Ltd Company Information
  33. 8.6.2 Abbexa Ltd Business Overview
  34. 8.6.3 Abbexa Ltd Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abbexa Ltd Rabies Diagnosis Product Portfolio
  36. 8.6.5 Abbexa Ltd Recent Developments
  37. 8.7 Norgen Biotek
  38. 8.7.1 Norgen Biotek Company Information
  39. 8.7.2 Norgen Biotek Business Overview
  40. 8.7.3 Norgen Biotek Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Norgen Biotek Rabies Diagnosis Product Portfolio
  42. 8.7.5 Norgen Biotek Recent Developments
  43. 8.8 EXPRESS BIOTECH INTERNATIONAL, INC.
  44. 8.8.1 EXPRESS BIOTECH INTERNATIONAL, INC. Company Information
  45. 8.8.2 EXPRESS BIOTECH INTERNATIONAL, INC. Business Overview
  46. 8.8.3 EXPRESS BIOTECH INTERNATIONAL, INC. Rabies Diagnosis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 EXPRESS BIOTECH INTERNATIONAL, INC. Rabies Diagnosis Product Portfolio
  48. 8.8.5 EXPRESS BIOTECH INTERNATIONAL, INC. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst